Induction of 11β-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli

Journal of Steroid Biochemistry and Molecular Biology

Volumn 77, Issue 2-3, 2001, Pages 117-122

  Cai, Tian Quan ^a   Wong, Birming ^a   Mundt, Steven S ^a   Thieringer, Rolf ^a   Wright, Samuel D ^a   Hermanowski Vosatka, Anne ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; CORTISONE; HYDROCORTISONE; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; HSD11B2 PROTEIN, HUMAN; HYDROXYSTEROID DEHYDROGENASE; PRIMER DNA;

AORTA MEDIA; ARTERY WALL; ARTICLE; BIOTRANSFORMATION; BRONCHUS MUSCLE; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG; MOLECULE; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STIMULUS; VASCULAR SMOOTH MUSCLE; AORTA; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; ENZYMOLOGY; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; AORTA; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; ENZYME INDUCTION; HUMANS; HYDROXYSTEROID DEHYDROGENASES; INFLAMMATION MEDIATORS; MUSCLE, SMOOTH, VASCULAR; RNA, MESSENGER;

EID: 0034744072     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00041-3     Document Type: Article

References (26)

1. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
2. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell. 93:1998;487-490.
3. Oppermann U.C., Persson B., Jornvall H. Function, gene organization and protein structures of 11beta-hydroxysteroid dehydrogenase isoforms. Eur. J. Biochem. 249:1997;355-360.
4. Tannin G.M., Agarwal A.K., Monder C., New M.I., White P.C. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J. Biol. Chem. 266:1991;16653-16658.
5. Ricketts M.L., Verhaeg J.M., Bujalska I., Howie A.J., Rainey W.E., Stewart P.M. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J. Clin. Endocrinol. Metab. 83:1998;1325-1335.
6. Chaman K.E., Kotelevtsev Y.V., Jamieson P.M., Williams L.J.S., Mullins J.J., Seckl J.R. Tissue-specific modulation of glucocorticoid action by the 11β-hydroxysteroid dehydrogenases. Biochem. Soc. Trans. 25:1997;583-587.
7. Kotelevtsev Y., Brown R.W., Fleming S., Kenyon C., Edwards C.R.W., Seckl J.R., Mullins J.J. Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2. J. Clin. Invest. 103:1999;683-689.
8. Wilson R.C., Dave-Sharma S., Wei J.Q., Obeyesekere V.R., Li K., Ferrari P., Krozowski Z., Shackleton C.H.L., Bradlow L., Wiens T., New M.I. A genetic defect resulting in mild low-renin hypertension. Proc. Natl. Acad. Sci. USA. 95:1998;10200-10205.
9. Whitworth J.A. Mechanisms of glucocorticoid-induced hypertension. Kidney Int. 31:1987;1213-1224.
10. Walker B.R., Yau J.L., Brett L.P., Seckl J.R., Monder C., Williams B.C., Edwards C.R. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology. 129:1991;3305-3312.
11. Hatakeyama H., Inaba S., Miyamori I. 11β-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension. Hypertension. 33:1998;1179-1184.
12. Krozowski Z., MaGuire J.A., Stein-Oakley A.N., Dowling J., Smith R.E., Andrews R.K. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J. Clin. Endocrinol. Metab. 80:1995;2203-2209.
13. Teelucksingh S., Mackie A.D., Burt D., McIntyre M.A., Brett L., Edwards C.R. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet. 335:1990;1060-1063.
14. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
15. Wang J.M., Shen W., Su S. Chemokines and their role in cardiovascular diseases. Trends Cardiovasc. Med. 8:1998;169-174.
16. Escher G., Galli I., Vishwanath B.S., Frey B.M., Frey F.J. Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. J. Exp. Med. 186:1997;189-198.
17. Tetsuka M., Haines L.C., Milne M., Simpson G.E., Hillier S.G. Regulation of 11beta-hydroxysteroid dehydrogenase type 1 gene expression by LH and interleukin-1beta in cultured rat granulosa cells. J. Endocrinol. 163:1999;417-423.
18. Handoko K., Yang K., Strutt B., Khalil W., Killinger D. Insulin attenuates the stimulatory effects of tumor necrosis factor alpha on11beta-hydroxysteroid dehydrogenase 1 in human adipose stromal cells. J. Steroid Biochem. Mol. Biol. 72:2000;163-168.
19. Stewart P.M., Krozowski Z.S. 11β-hydroxysteroid dehydrogenase. Vitamins Hormones. 57:1999;249-324.
20. Low S.C., Assaad S.N., Rajan V., Chapman K.E., Edwards C.R., Seckl J.R. Regulation of 11 beta-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. J. Endocrinol. 139:1993;27-35.
21. Leckie C., Chapman K.E., Edwards C.R., Seckl J.R. LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors. Endocrinology. 136:1995;5561-5569.
22. McMillen I.C., Warnes K.E., Adams M.B., Robinson J.S., Owens J.A., Coulter C.L. Impact of restriction of placental and fetal growth on expression of 11beta-hydroxysteroid dehydrogenase type 1 and type 2 messenger ribonucleic acid in the liver, kidney, and adrenal of the sheep fetus. Endocrinology. 141:2000;539-543.
23. R. Thieringer, C.B. Le Grand, S.S. Mundt, L., Carbin, S.Y.J., Ho, B. Wong, T.Q. Cai, S.D. Wright, A. Hermanowski-Vosatka, 11β-hydroxysteroid dehydrogenase type 1 is expressed in human monocytes upon differentiation to macrophages as well as in THP-1 cells, a human macrophage-like cell line, Presented at the 82nd Annual Meeting of the Endocrinology Society. June 21-24, 2000.
24. Ross R. Atherosclerosis -an inflammatory disease. New Engl. J. Med. 340:1999;115-126.
25. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2:1998;275-281.
26. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.